David discusses the importance of HDL functionality over mere levels, likening lipoproteins to boats transporting cholesterol. He emphasizes that a smaller, more active fleet can be more beneficial than a larger, inactive one. The lack of efficacy in drug trials may not be due to HDL itself, but rather its reduced activity in reverse cholesterol transport.
